Nigeria govt grants $54.9M for HIV/AIDS
Nigeria's federal government has authorized a 7.2-billion naira ($54.9 million) campaign against HIV/AIDS. Abdulsalim Nasidi, the Director of Special Projects at the Ministry of Health, announced the extra funding at a conference of the West African College of Physicians in Abuja, Nigeria.
In addition to the federal grant, Dr Nasidi confirmed increased funding for the College and stated that a new immunization strategy for Nigeria will be launched soon, according to the allAfrica.com news service.
One major concern in the West African country is in the area of polio vaccination. Bad publicity surrounding a number of people who developed polio as a result of the immunization process, and conspiracy theories about foreign drugmakers or the US government, have resulted in Nigeria being one of five countries still classified by the World Health Organization where the disease is endemic (Marketletters passim).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze